How Does Quantitative Data Help in Patient Selection for 177Lu-PSMA-617 Theranostics?
A review of recent literature shows promising evidence: Total tumor burden (TTB) metrics can aid physicians in their decision-making process to determine who will benefit most from 117Lu-PSMA-617 radioligand therapy (RLT).
5 minute read